iShares Nasdaq Premium Income Active (BALQ) ETF Holdings & Analysis
ETFOther
$54.68+0.39%
52-week range$54.68
$44.52$58.29
What BALQ does
The iShares Nasdaq Premium Income Active ETF's main objective is to generate current income, while also taking into account opportunities for capital growth.
Fund profile
Category
Other
AUM
$17.50M
Holdings
10
52-week high
$58.29
52-week low
$44.52
Top holdings
| Holding | Weight | |
|---|---|---|
| NVIDIA | 8.46% | |
| APPLE | 7.28% | |
| MICROSOFT | 7.00% | |
| AMAZON.COM INC | 5.01% | |
| MICRON TECHNOLOGY | 4.65% | |
| ADVANCED MICRO DEVICES | 3.59% | |
| ALPHABET CLASS A | 3.42% | |
| ALPHABET CLASS C | 3.09% | |
| BROADCOM INC | 3.09% | |
| BLK CSH FND TREASURY SL AGENCY | 2.97% |
Geographic allocation
| United States | 94.71% |
| Other | 4.54% |
| Bermuda | 0.30% |
| Sweden | 0.18% |
| Cayman Islands | 0.14% |
| Australia | 0.13% |
PortView Portfolio Insights
PortView analyzes how BALQ fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze BALQ in PortView →Related securities
Related stocks
Frequently asked questions
- What does BALQ track?
- BALQ is the iShares Nasdaq Premium Income Active ETF, a Other ETF.
- What is the expense ratio of BALQ?
- Expense ratio data for BALQ is shown on the page when available from our data provider.
- What are the largest holdings in BALQ?
- Top holdings include NVDA, AAPL, MSFT, AMZN, MU.
- How can PortView analyze BALQ overlap with other ETFs?
- PortView computes the holdings overlap between BALQ and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.